An Open-Label Trial Of Reduced- Dose Pylera, Amoxicillin, and Esomeprazole in the Treatment Of Helicobacter Pylori Infection
Condition(s):Treatment of H. Pylori InfectionLast Updated:January 15, 2015Withdrawn
Hide Studies Not Open or Pending
Condition(s):Treatment of H. Pylori InfectionLast Updated:January 15, 2015Withdrawn
Condition(s):Helicobacter Pylori Infection; Gastritis; Gastric CancerLast Updated:October 29, 2021Unknown status
Condition(s):Helicobacter Pylori InfectionLast Updated:February 9, 2017Withdrawn
Condition(s):Helicobacter Pylori InfectionLast Updated:April 26, 2019Terminated
Condition(s):Helicobacter InfectionsLast Updated:March 16, 2017Completed
Condition(s):H. Pylori InfectionLast Updated:April 14, 2011Unknown status
Condition(s):Helicobacter Pylori InfectionLast Updated:May 9, 2017Withdrawn
Condition(s):Helicobacter Pylori InfectionLast Updated:January 11, 2024Not yet recruiting
Condition(s):Helicobacter Pylori; Gut Microbiota; ImmunologyLast Updated:July 8, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.